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.13+ .02 7 c'ndlusicn: Igtkiqgcally ~-~ W b are GH defidart or GH ~d~ byBtandardpmcativetests, e x c r e t e l e s s~I F W t h a n~m b j~ S e x B t e r o i d s d o m t a p p e a r t a~r n l n e I I Q t W n e I I Q I~~ ~~f~m a i~~m n l n g G H t r e a~ An increased incidence of p e r i n a t a l problems has been r e p o r t e d i n c l a s s i c a l GH deficiency. We describe a s i m i l a r a s s o c i a t i o n i n c h i l d r e n w i t h GHND. Mean 24h GH concentrations were 2.0 + 0.1 ( 5 2 SE), 1.6 + 0.2 and 4.6 + 0.4 f o r GHND (n-17), G H def (n=15) and c o n t r o l (~~2 0 ) groups. Using c l u s t e r a n a l y s i s , t h e number of GH peaks was intermediate f o r GHND (6 + 1 ) between c l a s s i c a l G H def (5 + 1 ) and c o n t r o l (8 + 0 ) children. The number of low amplitude G H p u l s e s (peak (5 ng/mL) was h i g h e s t i n G H def and t h e r e was a g r e a t e r number of higher amplitude G H p u l s e s (peak 5-(10, 10-20, >20ng/mL) i n GHND compared t o c l a s s i c a l G H def but l e s s than controls.
Of 17 GHND p a t i e n t s , 11 had s i g n i f i c a n t problems: 1 ) twin conceptus l o s t a t 15 wk. g e s t a t i o n , 2 ) f e t a l bradyc a r d i a w i t h meconim s t a i n i n g , 3 ) septo-optic dysplasia w i t h RDS, hypoglycemia, hyperkalemia, 4 ) SGA a f t e r 2 i n t r a u t e r i n e blood t r a n s f u s i o n s , hypoglycemia, r e s p i r a t o r y d i s t r e s s , 5 ) hyperbilirubinemia r e q u i r i n g exchange t r a n s f u s i o n , 6 ) SGA, jaundice followi n g hemorrhage during pregnancy, hypoglycemia, r e s p i r a t o r y d i f f ic u l t y , 7 ) f e t a l d i s t r e s s , jaundice, 8 ) ''very premature appearing newborn" although f u l l term by d a t e s , 9) a b r u p t i o placenta. 1 0 ) 1 minute apgar of 4, 1 1 ) n e o n a t a l jaundice. These data suggest t h a t t h e r e a r e q u a n t i t a t i v e and q u a l i t a t i v e d i f f e r e n c e s i n G H p u l s e s between G H def and GHND children. GHND children, a s i n c l a s s i c a l GH def, have G H s e c r e t o r y abnormalities f r e q u e n t l y due t o p r e n a t a l and p e r i n a t a l complications.
DECRFASED GROWTH HORMONE (GH) BINDING TO IM-9 CELLS I N CHILDREN WITH BIOLOGICALLY INACTIVE G H SYNDROME (BI). Tzv B i s t r i t z e r S t u a r t A. Chalew J u d i t h C.
424 L o~c h i k ,~A .
Avinoam i o w a r s k i , IJniver.9;t.y o f Maryland School of Medicine, Department o f P e d i a t r i c s , Baltimore, MD.
We measured t h e r a t i o o f r a d i o r e c e p t o r a s s a y a b l e (RRA) t o r a d i o i m u n o a s s a y a b l e (RIA) GH i n : a / F i f t e e n normal s t a t u r e c h i l d r e n and young a d u l t s ( c o n t r o l s ) . b/ Seven poorly growing c h i l d r e n (neurosecretory; NS) who had normal G H R I A responses t o s t i m u l a t i o n but d e f i c i e n t 24-hour i n t e g r a t e d concentration of G H (IC-GH). c / S i x poorly growing c h i l d r e n ( b i o i n a c t i v e ; BI) who had normal G H s e c r e t i o n both to s t i m u l a t i o n and IC-GH.
The BI g r o u p was 9.123 (mean + SD) y e a r s o f a g e , bone a g e 6.122.7
y e a r s , IC-GH 6+2.4 ng/ml ( n o r m a l 3.2-12).
On GH t h e r a p y t h e g r o w t h r a t e o f BI p a t i e n t s i n c r e a s e d from 3.220.5 cm/yr t o 8.821.9 cm/year. R R A was a m o d i f i c a t i o n of a p r e v i o u s l y r e p o r t e d R R A u s i n g IM-9 lymphocytes.
The RRA/RIA was 1.320.4 i n c o n t r o l s , 1.5e.7 i n NS and 0.620.6 i n BI p a t i e n t s .
The d i f f e r e n c e i n R R A / R I A between BI p a t i e n t s and c o n t r o l s was s i g n i f i c a n t (P<0.005).
We c o n c l u d e t h a t 1 / The c i r c u l a t i n g GH o f NS p a t i e n t s h a s a 
D e p t o f Mol B i o l , B o s t o n ; O h i o U n i v , A t h e n s , OH.
T h e human g r o w t h h o r m o n e (hGH) g e n e f a m i l y c o n s i s t s o f 5 members l i n k e d on the long arm o f chromosome 17.
T h e hGH-A g e n e i s e x p r e s s e d by t h e s o m a t o t r o p h s o f t h e a n t e r i o r p i t u i t a r y . T h e hGH-B gene encodes a G H -l i k e p o l y p e p t i d e o f unknown f u n c t i o n . T o determine i f hGH-B i s c a p a b l e o f s t i m u l a t i n g g r o w t h i n animals, t r a n s g e n i c mice c o n t a i n i n g a m e t a l l o t h i o n i n e -I / h G H -B f u s i o n gene w e r e g e n e r a t e d . T h e GH produced b y these m i c e w a s compared w i t h p i t u i t a r y hGH-A, m o u s e GH, and hGH-A and hGH-B f r o m t r a n s f e c t e d mouse L c e l l f i b r o b l a s t s . T h e 3 t r a n s g e n i c male mice w e r e larger a t w e a n i n g ( 2 6 -3 1 g m s )
t h a n c o n t r o l m a l e s ( 2 0 2 0.4 g m s ) ; b y a g e 2 m o s t h e t r a n s g e n i c mice w e r e 4 0 -9 0 % larger t h a n t h e c o n t r o l s . g r o w t h i n mice. T h e d i f f e r e n c e s i n amino acid sequence b e t w e e n hGH-A and hGH-B r e s u l t i n s u b s t a n t i a l d i f f e r e n c e s i n t e r t i a r y and quanternary s t r u c t u r e .
ACROMEGALY PRESENTING I N INFANCY. Denise Blumberg, Charles S k l a r , J e n n i f e r B e l l and Raphael David. New York University and Columbia P r e s b y t e r i a n Medical Centers.Departments of P e d i a t r i c s , New York, New York.
We r e p o r t a female c h i l d w i t h a growth hormone (GH) s e c r e t i n g p i t u i t a r y adenoma and hyperprolactinemia. diagnosed a t 21 months, but w i t h c l i n i c a l s i g n s i n e a r l y infancy. Macrocephaly was noted a t 3 months, and by 21 months head c i rcumference was 55 cm (+5.5 SD). Linear growth was a c c e l e r a t e d by age 6 months, and a t 21 months h e i g h t was 98 cm (+4.4 SD). CT s c a n s a t 21 months showed a p i t u i t a r y tumor with s u p r a s e l l a r extension. Growth v e l o c i t y h a s remained normal ( 6 cm/yr) d e s p i t e p e r s i s t e n t l y low l e v e l s of G H (max 4.3 ngjml following i n s u l i n , L-Dopa and a r g i n i n e ) . TRH s t i m u l a t i o n f a i l e d t o e l i c i t a r i s e i n e i t h e r GH o r P r l . We suggest t h a t increased P r l r e s u l t e d from hypothalamic damage, and we s p e c u l a t e t h a t i t is r e s p o n s i b l e f o r normal growth and Somatomedin-C (Sm-C). There h a s been no r e c u r r e n c e t o d a t e (age 3% y r s ) . To our knowledge, t h i s is t h e youngest v e r i f i e d case of acromegaly reported. Twelve c h i l d r e n (10 g i r l s , 2 b o y s ) w i t h precocious puberty were t r e a t e d w i t h N a f a r e l i n , an i n t r a n a s a l GnRH analog, f o r 6 months. Seven p a t i e n t s (mean age o f 6.8 y r s ) r e c e i v e d 800 mcg and f i v e p a t i e n t s (mean age o f 7.8 y r s ) r e c e i v e d 1600 mcg d a i l y a t n i g h t . Standdrd LHRH t e s t s were performed and secondary sex c h a r a c t e r i s t i c s were assessed a t 0 , 3, and 6 months o f therapy. R e s u l t s a r e r e p o r t e d as mean + SE.
Following complete s u r g i c a l removal, immunohistochemi c a l s t a i n i n g of t h e tumor t i s s u e was p o s i t i v e f o r G H b u t n o t p r o l a c t i n ( P r l ) . P e r t i n e n t hormonal d a t a demonstrated t h e follow
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Peak LH (mIU/ml) 0 3mos 6mos 800 mcg 41.4~7.7 8 . 0~0 . 6 7.2~0.4 1600 ug 24.7t7.7 6.1+0.6 6.4t0.4 At 3 months o f t h e r a p y t h e h i g h e r d o s e o f n a f a r g l i n producFd a s i g n i f i c a n t l y g r e a t e r (pc.05) suppression o f peak LH l e v e l s d u r i n g t h e LHRH t e s t . These d i f f e r e n c e s were n o t s i g n i f i c a n t by s i x months o f therapy.
Regression o f b r e a s t development and r e d u c t i o n i n pubic h a i r appeared t o occur e a r l i e r i n t h e c h i l d r e n t r e a t e d w i t h t h e h i g h e r dose. These data suggest t h a t t h e h i g h e r dose o f N a f a r e l i n nay i n i t i a t e a more r a p i d suppression of serum LH response and n o r m a l i z a t i o n o f p u b e r t a l development. Follow-up s t u d i e s a r e e s s e n t i a l t o determine i f a more r a p i d decrease i n LH w i l l have a long-term impact on growth dynamics i n c h i l d r e n w i t h precocious puberty.
